Mission: The Ragon Institute seeks to support collaborative projects to overcome critical barriers in understanding protective immune responses in HIV infection, with the goal of developing an efficacious HIV vaccine.

The Ragon Institute is soliciting proposals from scientists and engineers from MGH, MIT, Harvard, and the Harvard affiliated hospitals who are interested in understanding the mechanisms underlying immune responses to chronic viral pathogens, and harnessing this understanding to conquer HIV/AIDS through the development of an AIDS vaccine. The overall goal is to integrate approaches rooted in biomedical research with those emerging from the physical sciences and engineering technology, and to create new cross-disciplinary synergies among faculty.

The next cycle of new applications for Ragon funding has been delayed until winter. An announcement regarding the nature and timing of the cycle of awards will be forthcoming. However, if you are interested in submitting a renewal application for an innovation award, applications will be due Friday October 8; please contact ragonrfa@partners.org for details.

If you would like to receive updates on the Ragon RFA send an email to ragonrfa@partners.org with the subject line "Subscribe".